News

'Survivor' Winner Reveals Shocking Weight Loss originally appeared on Parade. Kyle Fraser, winner of Survivor 48, took to ...
The public response to Rebel Wilson's weight loss surprised her. In the June 4 episode of the Let's Talk Off Camera with ...
After fans took notice of her new appearance, Trainor addressed her significant weight loss on Instagram, attributing her transformation to "huge lifestyle changes" such as using the weight-loss ...
The statement also said, in part, that "robust data" supporting Wegovy's "meaningful and unique benefits continue to grow" and that in addition to "offering significant and sustained weight loss ...
Larger studies are needed to confirm the findings, which offer the latest evidence that the medicines can do much more than help people lose weight. Blockbuster weight loss drugs may help people ...
Another win for the jab. GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk to addiction treatment.
Challenge host Kelly Heidbreider recaps the events. Panama president says he will not renegotiate security deal with US, despite protests A New Pope Has Been Elected Ellen DeGeneres shares rare ...
Eli Lilly's (LLY) stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker ...
As part of its RAK Weight Loss Challenge 2025, the hospital recently hosted a Obefit Webinar titled The Psychology of Weight Loss led by clinical psychologist Savita Date. The session discussed ...
As Ozempic and other GLP-1 medications continue to grow in popularity for weight loss, a concoction dubbed "oatzempic" is trending. The blended beverage, which consists of oats, lime juice ...
How Does Topirmate for Weight Loss Work? This article was reviewed by Mike Bohl, MD, MBA, MPH, MS, ALM. Topiramate, also sold under the brand name Topamax, is a drug approved by the U.S. Food and ...
Eli Lilly's Mounjaro (Tirzepatide), a dual GIP and GLP-1 receptor agonist, has launched in India, generating buzz as a weight loss drug similar to Ozempic. Gastroenterologist Dr. Pal Manickam ...